Loomis, Sayles & Company
NVRO

Loomis, Sayles & Company’s NEVRO CORP. NVRO Stock Holding History

Loomis, Sayles & Company’s Portfolio NVRO Stock Details NVRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-175,488
Closed -$16.4M – 1011
2017
Q1 		$16.4M Sell
175,488
-3,950
-2% -$358K 0.04% 313
2016
Q4 		$13M Buy
179,438
+15,367
+9% +$1.32M 0.03% 373
2016
Q3 		$17.1M Sell
164,071
-39,928
-20% -$3.61M 0.04% 308
2016
Q2 		$15M Buy
+203,999
New +$13.8M 0.04% 346

Other funds holding NVRO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Loomis, Sayles & Company's NVRO Position: Q2 2017 in Review

Loomis, Sayles & Company sold out of NEVRO CORP. (NVRO) in Q2 2017, closing a stake of 175,488 shares — an estimated $16.4M sold.

Loomis, Sayles & Company first reported a position in NVRO in Q2 2016 and held it in 4 quarters. The position peaked at $17.1M in Q3 2016. 201 funds tracked by Wall St. Rank hold NVRO as of Q2 2017.

  • Loomis, Sayles & Company reported no remaining NEVRO CORP. position as of Q2 2017 after selling out during the quarter.
  • Loomis, Sayles & Company sold 175,488 NEVRO CORP. shares in Q2 2017, an estimated $16.4M.
  • Loomis, Sayles & Company first reported a position in NEVRO CORP. in Q2 2016 and held it in 4 quarters.
  • Loomis, Sayles & Company's NEVRO CORP. position peaked at $17.1M in Q3 2016.
  • 201 funds tracked by Wall St. Rank held NEVRO CORP. as of Q2 2017.

Based on Loomis, Sayles & Company's 13F filing for Q2 2017, filed 14 Aug 2017.